Structure Therapeutics (GPCR) is up 14.1%, or $9.79 to $79.15.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GPCR:
- Validating IP, Extending Runway: Why Structure Therapeutics’ Oral GLP‑1 Platform Supports a Buy Rating
- Structure Therapeutics inks major GLP-1 licensing deal
- Structure Therapeutics price target raised to $90 from $60 at H.C. Wainwright
- Structure Therapeutics announces initiation of Phase 1 study of ACCG-2671
- Structure Therapeutics price target raised to $125 from $120 at Morgan Stanley